Nguyen Kytai Truong, Shukla Kajal P, Moctezuma Miriam, Braden Arthur R C, Zhou Jun, Hu Zhibing, Tang Liping
Department of Bioengineering, The University of Texas at Arlington, Arlington, Texas 76019, USA.
J Biomed Mater Res A. 2009 Mar 15;88(4):1022-30. doi: 10.1002/jbm.a.31734.
Intensive research efforts have been placed on the development of nanospheres for targeted drug delivery for treating a variety of diseases, including coronary restenosis, cancer, and inflammatory reactions. Although most of these drug-bearing spheres are delivered via intravenous administration, little is known about the effect of sphere physical characteristics on the responses of vascular and blood cells. To find the answer, this work was aimed to investigate the cellular uptake of nanosized (100 nm) and microsized hydrogel spheres (1 microm) made of poly(N-isopropylacrylamide) by vascular cells and phagocytes under various flow conditions in vitro. We found that the cellular uptake of nanospheres depended on incubation times and sphere concentrations as well as on the introduced shear stress levels of the medium. Measurements of the intracellular-released fluorescence and confocal fluorescence microscopy revealed that nanospheres were internalized by endothelial cells and smooth muscle cells more than microspheres, whereas microspheres were rapidly taken up by phagocytes, especially at high concentration. Our results strongly suggest that hydrogel nanospheres are more effective as an intravascular delivery system compared to microspheres in the terms of vascular cellular uptake and biocompatibility.
为了开发用于治疗包括冠状动脉再狭窄、癌症和炎症反应在内的多种疾病的靶向给药纳米球,人们进行了大量深入的研究。尽管大多数这些载药球体是通过静脉给药的,但关于球体物理特性对血管和血细胞反应的影响却知之甚少。为了找到答案,这项工作旨在研究在体外各种流动条件下,由聚(N-异丙基丙烯酰胺)制成的纳米级(100纳米)和微米级水凝胶球体(1微米)被血管细胞和吞噬细胞摄取的情况。我们发现,纳米球的细胞摄取取决于孵育时间、球体浓度以及培养基引入的剪切应力水平。细胞内释放荧光的测量和共聚焦荧光显微镜观察表明,纳米球被内皮细胞和平滑肌细胞内化的程度超过微球,而微球则被吞噬细胞迅速摄取,尤其是在高浓度时。我们的结果有力地表明,就血管细胞摄取和生物相容性而言,水凝胶纳米球作为血管内给药系统比微球更有效。